Eagle Pharmaceuticals to Present at 31st Annual Piper Jaffray Healthcare Conference

Wednesday, November 20, 2019 6:50 am EST

Dateline:

WOODCLIFF LAKE, N.J.

Public Company Information:

NASDAQ:
EGRX

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 31st Annual Piper Jaffray Healthcare Conference as follows:

 

Date:

Tuesday, December 3, 2019

Time:

11:30 a.m. Eastern Standard Time

Location:

Lotte New York Palace, New York, NY

Webcast:

https://event.webcasts.com/starthere.jsp?ei=1273124&tp_key=d0b36ea10f

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors + News Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing innovative and differentiated injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Additional information is available on the Company’s website at www.eagleus.com.

Multimedia Files:

Preview image

Contact:

Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Business Wire InvestorHQsm